Author information: (1)Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, New York, NY, USA. (2)Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. (3)Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, New York, NY, USA. (4)Seqirus, Cambridge, MT, USA. (5)Texas Biomedical Research Institute, San Antonio, TX, USA. (6)Moderna Therapeutics, Cambridge, MT, USA. (7)Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, NY, USA. (8)Center for Comparative Medicine and Surgery, Icahn School of Medicine at Mount Sinai New York, New York, NY, USA. (9)Department of Pharmaceutics, Ghent University, Ghent, Belgium. (10)Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA. (11)Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai New York, New York, NY, USA. (12)Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, New York, NY, USA. Adolfo.Garcia-Sastre@mssm.edu. (13)Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, New York, NY, USA. Adolfo.Garcia-Sastre@mssm.edu. (14)Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai New York, New York, NY, USA. Adolfo.Garcia-Sastre@mssm.edu. (15)The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai New York, New York, NY, USA. Adolfo.Garcia-Sastre@mssm.edu. (16)Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, New York, NY, USA. michael.schotsaert@mssm.edu. (17)Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, New York, NY, USA. michael.schotsaert@mssm.edu. (#)Contributed equally